Im, Jisu https://orcid.org/0000-0003-0972-3048
Hillenaar, Tamara https://orcid.org/0000-0003-0672-2947
Yeoh, Hui Ying
Sahasrabudhe, Priyanka https://orcid.org/0000-0002-8666-0055
Mijnders, Marjolein https://orcid.org/0000-0002-2962-0479
van Willigen, Marcel https://orcid.org/0000-0003-3510-7564
Hagos, Azib
de Mattos, Eduardo https://orcid.org/0000-0001-9395-2059
van der Sluijs, Peter https://orcid.org/0000-0002-4485-3342
Braakman, Ineke https://orcid.org/0000-0003-1592-4364
Funding for this research was provided by:
Cystic Fibrosis Foundation Therapeutics (BRAAKM14XX0)
Cystic Fibrosis Foundation Therapeutics (BRAAKM18G0)
Nederlandse Cystic Fibrosis Stichting (HIT CF)
Nederlandse Cystic Fibrosis Stichting (HIT CF 2.0)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (022.004.019)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (731.016.403)
Horizon 2020 Framework Programme (H2020-MSCA-IF-2017 Mem-Chaps)
EMBO (ALTF 1085-2017)
ZonMw (40-00812-98-14103)
Stichting Zeldzame Ziekten Fonds (Helpende handen om CF te genezen)
Cystic Fibrosis Trust (SRC 021)
Article History
Received: 20 July 2022
Revised: 1 November 2022
Accepted: 28 November 2022
First Online: 7 January 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.